Private Right of Action under the FCPA? Risks increase as litigants increasingly use foreign bribery allegations as predicate acts in U.S. civil tort cases.
Client Alert | 2 min read | 10.29.08
For at least the third time this year, a civil case has been brought in U.S. federal court alleging conduct that, if proven, would likely constitute a violation of the Foreign Corrupt Practices Act.
Last week, Supreme Fuels Trading FZE, a company incorporated and headquartered in the UAE, filed a lawsuit in federal district court in Miami against, among others, prominent political fundraiser Harry Sargeant III and his company, International Oil Trading Company (IOTC). The lawsuit alleges that Sargeant and others participated in a conspiracy to bribe Jordanian government officials to obtain necessary documents that would ensure the receipt of over $1 billion in U.S. government contracts for the supply of fuels to the U.S. military in Iraq.
According to the Complaint, the U.S. military fuel contracts required eligible bidders to obtain a "Letter of Administration" or "LOA" from the Jordanian government permitting the transport of fuels across Jordan into Iraq. Supreme Fuels claims that it presented more favorable bids than Sargeant and his partners, but that the defendants paid tens of millions of dollars to ensure that they were the exclusive recipients of the required LOAs.
Supreme Fuels claims that the conspiracy netted IOTC more than $210 million in profits, and Sargeant himself more than $70 million. Supreme Fuels complains further that the scheme cost U.S. taxpayers more then $180 million in overpayments.
There is no private right of action under the FCPA, but companies, and even foreign governments, have taken to U.S. courts seeking damages for the same conduct under the federal Racketeering Influenced and Corrupt Organizations Act ("RICO") as well as state and federal antitrust, consumer protection, and tort laws. With the added exposure of civil lawsuits, companies accused of foreign bribery not only face the prospect of multi-million dollar fines or settlements with the U.S. Department of Justice and Securities and Exchange Commission, but also treble damages under RICO and other civil remedies.
With U.S. and other governments continuing to expand their investigations of foreign bribery, companies are learning the hard way the importance of establishing and maintaining an effective global anti-corruption compliance and training program. With civil plaintiffs now joining the ranks of those "prosecuting" foreign bribery, the stakes have only gotten higher.
Contacts
Insights
Client Alert | 2 min read | 02.03.26
CMS Doubles Down on RADV Audit Changes
On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) released a Health Plan Management System (HPMS) memo that provided a long-awaited update on how the agency plans to approach previously announced Risk Adjustment Data Validation (RADV) audits for Payment Years (PY) 2020-2024. The memo is the agency’s most comprehensive statement on the subject since September 25, 2025, when the Northern District of Texas vacated the 2023 RADV Final Rule. The memo makes clear that, while CMS has made certain operational adjustments in response to concerns expressed by Medicare Advantage Organizations (MAOs), the agency is largely pressing forward with the accelerated audit strategy announced in May 2025.
Client Alert | 2 min read | 02.03.26
Sedona Model Jury Instructions for DTSA: A Step Forward—But Questions Remain
Client Alert | 7 min read | 01.30.26
CMS Proposes CY 2027 Growth Rate and Changes to Risk Adjustment for Medicare Parts C and D
Client Alert | 4 min read | 01.30.26
Optimum’s Shot Across the Bow: An Antitrust Challenge to Cooperation Agreements


